𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hearing Loss in Children with Osteogenesis Imperfecta (OI) Treated with Bisphosphonates

✍ Scribed by Christi A. Arnerich; Aaron C. Moberly; Linda A. Dimeglio; Richard T. Miyamoto


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
582 KB
Volume
119
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

✦ Synopsis


21.4% of children developed hearing loss, a percentage similar to previous population studies.

β€’ Since all received treatment, we cannot determine directly bisphosphonate effects on hearing loss over time. β€’ However, it appears that bisphosphonates neither increase hearing loss nor stop progression in these children.


πŸ“œ SIMILAR VOLUMES


A fracture risk assessment model of the
✍ Jessica M. Fritz; Yabo Guan; Mei Wang; Peter A. Smith; Gerald F. Harris πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 561 KB

Osteogenesis imperfecta (OI) is a heritable bone fragility disorder characterized by skeletal deformities and increased bone fragility. There is currently no established clinical method for quantifying fracture risk in OI patients. This study begins the development of a patient-specific model for fe

Sensorineural hearing loss in children a
✍ Jeffrey A. Marler; Jill L. Elfenbein; Brenda M. Ryals; Zsolt Urban; Michael L. N πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 281 KB πŸ‘ 3 views

## Abstract Williams syndrome (WS) is a genetic neurodevelopmental disorder, most often accompanied by mild‐to‐moderate mental retardation. Individuals with WS show unique communication strengths and impairments that are challenging to treat in community, educational, and vocational settings. Many